Investors

Shareholder Information

Incanthera plc's shares are traded on the Access Segment of AQSE Exchange Growth Market, Updated as of 23 April 2024.

Symbol: INC

ISIN GB00BGL7YW15
LEI code 2138002HEV4UFBOEXQ97

There are no restrictions on the transfer of AQSE Securities.

The main country of operation is United Kingdom. Incorporated and registered in England and Wales with registered number 11026926.

Incanthera plc is subject to the City Code on Takeovers and Mergers.

Shareholder Analysis

No. of shares in issue:
99,276,547
Warrants outstanding: 12,131,516
Options outstanding: 9,175,000
Fully diluted:
120,583,063 
Percentage of Shares in public hands: 43.53%
Percentage of Shares not in public hands: 56.47%

Major Shareholdings

Shareholder Number of shares held % of issued share capital

Tyndall Investment Management

16,238,782

16.36%

NWF (Biomedical) LP

16,164,540

16.28%

University of Bradford

10,349,183

10.42%

Immupharma Plc

9,904,319

9.98%

The Bank Of New York (Nominees) Limited

4,152,311

4.18%

Mr Tim McCarthy

3,931,646

3.96%

Dr. Simon Ward

3,064,199

3.09%

Contact:

Head of Communications & Company Secretary
Suzanne Brocks
Suzanne.brocks@incanthera.com